In this podcast episode, Dr. Mansour interviews Cardiothoracic surgeon Dr. Joseph Zwischenberger “Zwisch,” who is a key member of the team at Verthermia. Dr. Zwisch and Dr. Mansour discuss the novel and FDA-approved innovative technique called HEATT® (Hyperthermic Extracorporeal Applied Tumor Therapy) — used for end-stage/terminal cancer.

Join Dr. Zwisch and Dr. Mansour as they further discuss the clinical parameters, applications, indications, and contraindications of this pioneering technique, harnessing the power of heat as a hormesis stressor to modulate immune function in the setting of cancer. Similar to EBOO (extracorporeal blood ozonation and oxygenation), HEATT® is an exciting and promising modality that may also have future applications for modulating dysregulated immune function in light of viral infections as well as complex ch ...